Management & Regulatory

Will New Data Privacy Campaign Protect NM Health Data?
Management & Regulatory Will New Data Privacy Campaign Protect NM Health Data?

In an era where personal data is often treated as a commodity, New Mexico's recent initiative seeks to offer a robust shield against potential misuse and exploitation. Launched by the New Mexico Community & Health Information Safety & Privacy Advocacy (NMCHISPA), this campaign highlights the

Can Sterile Packaging Keep Pace with Healthcare Demands?
Management & Regulatory Can Sterile Packaging Keep Pace with Healthcare Demands?

The burgeoning demands of the healthcare industry have put the spotlight on sterile packaging, a pivotal element in ensuring the safety and efficacy of medical products and devices. As healthcare facilities worldwide grapple with escalating cases of chronic diseases, the need for impeccable

Why Are Clinical Trials Key to Medical Advances at UAMS?
Management & Regulatory Why Are Clinical Trials Key to Medical Advances at UAMS?

Clinical trials stand as a cornerstone in the journey toward medical advancements, acting as the bridge that connects theoretical research with practical, patient-centered care. At the University of Arkansas for Medical Sciences (UAMS), clinical trials are a celebrated and integral part of

Is Healthcare Prepared for Rising Cyber Threats in Abu Dhabi?
Management & Regulatory Is Healthcare Prepared for Rising Cyber Threats in Abu Dhabi?

In an era defined by rapid technological evolution, the healthcare sector in Abu Dhabi faces pressing challenges due to escalating cyber threats. Recognizing this, the Department of Health – Abu Dhabi (DoH) recently conducted a comprehensive cybersecurity drill, underscoring the need for resilience

AHA Urges Reforms to Address Insurers' Market Dominance
Management & Regulatory AHA Urges Reforms to Address Insurers' Market Dominance

The American Hospital Association (AHA) has put forth a series of recommendations aimed at reforming policies to mitigate health insurers' growing dominance in the market, focusing on recent developments that exacerbate competition challenges. The AHA has submitted these recommendations to the

FDA Approves First Blood Test for Early Alzheimer's Detection
Management & Regulatory FDA Approves First Blood Test for Early Alzheimer's Detection

In a significant advancement for Alzheimer's disease diagnosis, the US Food and Drug Administration (FDA) has approved a new and groundbreaking diagnostic tool, the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio blood test. Developed by Fujirebio Diagnostics, this test offers a less invasive and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later